chrisvoncsefalvay/vaers-outcomes huggingface dataset:
a funny metallic taste in her mouth; she felt like she had cotton mouth; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose of bnt162b2 (COVID 19 vaccine) lot no: EH9899, via an unspecified route of administration in left arm on 21Dec2020 08:00 at a single dose for COVID-19 immunization.  Medical history included diabetic type 2 and allergic to metal, both from an unknown date and unknown if ongoing. Concomitant medication included ongoing metformin hydrochloride (METFORMIN ER) for diabetes, taking for a couple of years. The patient received the vaccine on 21Dec2020 8am at her hospital, and by 10:30AM or 11:00AM she noticed "a funny metallic taste in her mouth." She stated it was like a metal cup a tin taste like that and she wanted ice water. The patient is a phlebotomist, she continued with her patients and asked a co-worker did you taste/experience that, coworker stated "I've had covid"; she didn't get the vaccine taste metal in your mouth. The reported wanted to know if that is an expected side effect of the vaccine. She can smell everything. She still has taste buds. It was still there but not as strong. She stated that she felt fine, and doesn't feel anything. She doesn't feel bad. She was just wondering about the side effects.  She drank a lot of water. The patient added that all of the sudden her mouth was tasting funny like nickel. She added that she is allergic to metal; stated she can taste the tin in a tin can. She was working in the ER after having received the first dose injection at 8:00AM on 21Dec2020. She started to taste the funny taste about two hours later, 10:30AM or 11:00AM. She drank some ice water and it kind of rinsed her mouth out then she only tasted it a tiny bit. Then she felt like she had cotton mouth. It has improved but not gone away. She received the injection in her left arm. She is scheduled 11Jan2021 for the next dose. The patient was recovering from the events. The sample of the product is not available to be returned.
pain during injection; cried with the poke; Inappropriate reconstitution technique; Inappropriate reconstitution technique; This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a 12-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA055A, expiry date 30th November 2019) for prophylaxis.   On 5th April 2019, the patient received Menveo. On 5th April 2019, immediately after receiving Menveo, the patient experienced injection site pain, crying, inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the injection site pain, crying, inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the injection site pain and crying to be related to Menveo.  Additional details were provided as follows: The batch number of powder portion of Menveo was reported, that was inadvertently not given. The patient received the liquid component of the Menveo only, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter reported, the patient cried with the poke. No additional information was reported.
Vaccine administered after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information were not provided  Treatment medication information were not reported
After dose 1 I had a heavier than usual period two weeks early; After dose 1 I had a heavier than usual period two weeks early; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 16:00 (at the age of 39-year-old) as dose 1, single for COVID-19 immunisation. Medical history included hypothyroid, polycystic ovarian syndrome (PCOS) (but consistently controlled for 10 years with weight loss and metformin). The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included levothyroxine (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) and spironolactone (MANUFACTURER UNKNOWN), all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. After dose one the patient had a heavier than usual period two weeks early on 04Apr2021. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event after dose one had a heavier than usual period two weeks early was resolved on an unknown date in Apr2021.   No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a 79 years old female consumer reporting on herself with no pertinent medical history and allergy to anything with antihistamines, who on 20-JUN-2012, was vaccinated subcutaneously with a 0.65 ml single dose of ZOSTAVAX (lot number not reported). No other co-suspects were reported. Concomitant medications included: CLARITIN. The consumer reported that on 21-JUN-2012, she had severe swelling and redness for two days, after receiving ZOSTAVAX. No treatment was given for the experience. No lab diagnostics studies were performed. It was stated that the event started to clear on the third day and the consumer recovered after a week on 30-JUN-2012. The consumer believed that it was an allergic reaction. The patient did not seek medical attention. The relatedness for patient had severe swelling, redness and an allergic reaction was unknown for ZOSTAVAX. Additional information is not expected.
Real dizzy; Nausea; Headache; This is a spontaneous report from a contactable consumer (patient's brother). A 30-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown) via an unspecified route of administration on 17Apr2021 16:43 in right arm as single dose for COVID-19 immunisation. The patient medical history and concomitant medication was not reported. There was no history of previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer Suspect. There were no prior vaccinations within 4 weeks. It was stated that the patient received the first dose of the Pfizer COVID 19 vaccine last Saturday, 17APR2021 at 16:43 PM in the right arm. That day she got a headache, Saturday night (17Apr2021). Then today she woke up real dizzy (20Apr2021 06:20). She wants to know what kind of medication she can take for dizziness. It was also reported that when the patient stands up it gets worse. On 20Apr2021 06:20 am this morning she woke up and felt a little nausea, but she does not have that anymore. She just wants to take something so she can go to woke. Mentions she took Tylenol. The patient did not visit emergency room or physician Office. The outcome of the event headache was recovered/resolved on 17Apr2021 and nausea on 20Apr2021. The outcome of the event dizziness was not recovered.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
This spontaneous report as received from a nurse refers to unspecified patients of unknown age and gender. On an unknown date the patients were vaccinated with ZOSTAVAX (Lot# N009167 with expiration date 02-FEB-2018, Lot# reported as N012492 with expiration date 17-MAR-2018) for prophylaxis which were reconstituted with diluent. On an unknown date the patients were vaccinated with the vaccines that were improperly stored between 6F to 14F (9F) with the time frame of 3 hours and 45 minutes. There was no previous temperature excursion. No data logger was involved. No adverse effects were reported. Diluent was not involved in the temperature excursion. This is one of several reports received from the same source. Sender's Comments: US-009507513-1707USA009510: US-009507513-1707USA009490.
Chest pains, high blood pressure,  numbness on arm, neck, face. Short of breath,  weak and dizziness
Chest Pressure where my heart is, right in the middle.; Discomfort all the time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Sep2021 14:00 (Lot number: 2589) at the age of 48 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PROGESTERONE; ESTROGEN; MULTIVITAMIN [VITAMINS NOS]. Past drug history included: Sulfa, reaction(s): "Allergy". The following information was reported: CHEST DISCOMFORT (non-serious) with onset 25Sep2021 04:00, outcome "not recovered", described as "Chest Pressure where my heart is, right in the middle."; DISCOMFORT (non-serious) with onset 25Sep2021 04:00, outcome "not recovered", described as "Discomfort all the time". Therapeutic measures were not taken as a result of chest discomfort, discomfort.  Additional information: Chest Pressure where heart is, right in the middle. Feels like patient have 30 pounds sitting on chest. Discomfort all the time. Started 4 days after shot and patient still have the issue 10 days later. Patient healthy and never had heart issue before. Patient had most recent Covid-19 vaccine in Pharmacy or Drug Store facility. Patient did not received any other vaccine within 4 weeks of Covid-19 vaccine. Patient was not diagnosed with Covid-19 prior to vaccination. Patient was not tested for Covid-19 since vaccination.  No follow-up attempts are possible. No further information is expected.
Information has been received from a registered nurse concerning an 18 month old male with eczema and no known allergies who on 1/27/04 at 9 AM was vaccinated SC in the left thigh with a first dose of varicella virus vaccine live. Concomitant vaccination included a fourth dose of pneumococcal 4 6B 9V 14 18C 19F 23F conjugate vaccine (lot # 495033) given IM in the right thigh. There was no illness at the time of vaccination. On 7/1/04, the patient developed an itchy rash which started as small bump over a few days and became larger with a head. No chicken pox exposure was known. He was seen in the office and diagnosed with chicken pox. He had approximately 15-20 lesions on his legs, arms, and face and none on his palms or soles. He was advised symptomatic treatment, isolate till lesions were crusted over and to call PRN with signs and symptoms of illness. on 7/8/04 the nurse reported that the patient was recovering. No adverse events following prior vaccination were known. There was no product quality complaint. Follow up information from the nurse indicated that the physician has seen the patient since his chicken pox and the child was doing fine. No further information is expected.
Mother reports temp 102 deg at 5am 06/05/02, went up to 104 degrees. Child not medicated with Tylenol until febrile. Sent to PMD. Mother also reports HA and generalized soreness. On 06/16/02 reports still has temp 102 deg and lethargic. Temp decreased to 100 degrees with Tylenol and HA on 06/07/02.
Following vaccine there was tenderness and a red patch avout 1 inch in diameter for about 2 days. then resolved and noticed nothing from day 3 - 9. On day 10, noticed a red ring, mostly circular around the injection site, about 3 inchec in diameter. No pain, very mild swelling. Day 11, red ring was larger, less circular. Still no pain, mild swelling. Day 12, much larger ring, 6+ inches. Mild swelling, no pain. warm to touch.
Intermittent nerve pain; Still in pain; shingles; painful rash on right side of face; mild arm pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (mild arm pain), HERPES ZOSTER (shingles), PAIN (Still in pain), RASH (painful rash on right side of face) and NEURALGIA (Intermittent nerve pain) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 006M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021 at 2:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021 at 2:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (mild arm pain). On 01-Feb-2021, the patient experienced RASH (painful rash on right side of face). On 05-Feb-2021, the patient experienced HERPES ZOSTER (shingles). On 06-Feb-2021, the patient experienced PAIN (Still in pain). On an unknown date, the patient experienced NEURALGIA (Intermittent nerve pain). On 16-Feb-2021, HERPES ZOSTER (shingles) and RASH (painful rash on right side of face) had resolved. At the time of the report, PAIN IN EXTREMITY (mild arm pain), PAIN (Still in pain) and NEURALGIA (Intermittent nerve pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment  included ,Valacyclovir 1gram q 8 hours, Gabapentin 100mg up to 3 tab PRN, Hydroxyzine HCl 25mg PRN for itching.  Patient discontinued  Vancyclovir on 15-FEB-2021   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow-up was Received on 21-APR-2021 Added Patient Demographics.The Stop date of the event Herpes Zoster,Rash was added (16-02-2021). Details Regarding the Dose 2 added.Updated the outcome of the event Pain in extremity, Herpes zoster, Pain, Neuralgia, Rash was updated from Unknown to Recovered
Got sick after getting the Pfizer Covid 19 vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Got sick after getting the Pfizer Covid 19 vaccine".  Additional information: It was reported that " Caller states that she had 2 young adult children that got sick after getting the Pfizer Covid 19 Vaccine, and also her Uncle and her brother. She was only looking to find a medication or product so they can get immediate relief, but she was not finding any products that can help them. She just wants to know if there was a product that can alleviate the symptoms, or is it just pushing the vaccine. Verified that all patients received the Pfizer Covid 19 Vaccine. This report was for the caller's brother.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300056731 same reporter, product and event, different patient (report 3 of 5);
RN inserted the needle partially into the client's arm and noted fluid dripping on the client's arm. RN did not remember activating the plunger of the syringe. Once RN noted the liquid on the client's arm she removed the needle. Lead RN was notified of the events. Per CDC guidance, the client received a repeat dose of 0.3 mL of Pfizer COVID vaccine (Lot#FL3209 exp: 06/30/2022) in the right arm at 2:13 PM. The client did not report any symptoms during the 15 minute observation period. RN educated client on possible adverse reactions and when to seek medical care. The client left the vaccination site ambulating unassisted with a steady gait.
8 days after the shot, I got a large, red, very hot, itchy rash that still has not gone away after two weeks. Symptoms still include spreading of rash (not nearly as red though), it's still hot to the touch and itchy.
COVID 19 treatment; COVID 19 treatment; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  An 80-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Oct2022 at 01:15 as dose 5 (booster), single (Lot number: GJ5342) at the age of 79 years, in right arm for COVID-19 immunisation; BNT162b2 (BNT162B2), on 27Jan2021 at 14:30 as dose 1, single (Lot number: EL2963), in right arm, on 23Feb2021 at 14:30 as dose 2, single (Lot number: EN6201), in right arm, on 31Oct2021 at 13:15 as dose 3 (booster), single (Lot number: FF2587), in right arm and on 31May2022 as dose 4 (booster), single (Lot number: FM9992), in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 treatment". Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid from 19Mar2023 to 24Mar2023.
fever; 4 month old was administered Kinrix; This case was reported by a nurse via call center representative and described the occurrence of fever in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number 2KL4K, expiry date 9th November 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, less than 4 months after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced fever and inappropriate age at vaccine administration. On an unknown date, the outcome of the fever and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the fever to be related to Kinrix and Kinrix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-Oct-2022 Reporter's comment:  The registered nurse reported a 4 month old was administered a dose of Kinrix in error. The patient developed a fever.  The vaccine administration facility was the same as primary reporter. The registered nurse did not ask about follow up but address, email and phone are above in healthcare professional details. The healthcare professional stated they had reported to VAERS already. Additional Supportive Information: 4 month old patient was administered a dose of Kinrix in error, which led to inappropriate age at vaccine administration.
Received flu vaccine and afterwards developed weakness in left side of face.after two days doctors diagnosed as bells palsy.
It sounds like he has a cold; pressure headache; congestion stuffy nose; flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion stuffy nose), INFLUENZA LIKE ILLNESS (flu-like symptoms), NASOPHARYNGITIS (It sounds like he has a cold) and HEADACHE (pressure headache) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 006C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2021, the patient experienced NASAL CONGESTION (congestion stuffy nose), INFLUENZA LIKE ILLNESS (flu-like symptoms) and HEADACHE (pressure headache). On an unknown date, the patient experienced NASOPHARYNGITIS (It sounds like he has a cold). At the time of the report, NASAL CONGESTION (congestion stuffy nose) and NASOPHARYNGITIS (It sounds like he has a cold) outcome was unknown, INFLUENZA LIKE ILLNESS (flu-like symptoms) had not resolved and HEADACHE (pressure headache) had resolved.            No Concomitant Medication was provided.  No treatment  was provided.
one week post vaccine pt developed acute delirum was unable to recognized family members, was not oriented to placed time, self was hospitalized for event and all testing negative for stroke, heart attack, no abnormal lab values
Patient experienced fatigue and headache for 3 days after immunization that went away, but has had a recurring headache also ever since that feels different from headache she may have had prior to vaccination, and was not having recurring headaches prior to vaccination
Pt. had appt. on 8-22-11 for vaccine update. She received PENTACEL = DTaP 5, IPV 4, Hib 4 on (R) Th, varicella #2 on (R) Th, PCV13 #5 on (L) Th, MMR #2 on (L) Th, HepA #2 (L) Th. Mom noticed on night of 8-23-11 swelling, warmth and redness. Per mom she applied ice pack. Today per mom looks better. Per Dr. keep applying ice and MOTRIN.
All Night into the following day: 101 Fever  Chills (freezing shakes) Labored Breathing (for hours all night long) Nauseous Dull Headache Pain in arm (felt like 10 pounds) and body aches
Redness, heat, swelling, itching at injection site starting 11/4/21. Fever and chills on 11/4/21 lasting one day. Redness, heat, swelling, itching lasting 5 days.   Fever's highest point was 100.3* at 3:30am on 11/4/21. It stopped until around 5:30 where the fever and chills started again. It subsided  later on and I was able to attend work on 11/5/21.
After receipt of Pneumococcal Pneumonia vaccine Pt developed redness, swelling and itching at site of injection. Over 48 hours this came to involve half the upper arm and circumferencing the arm. Discomfort and itching left pt up for two nights and was administered a sec inj of cortisone.